MARIO ESPINDOLA: Open Payments
NPI 1750657565 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 8 | $140 |
| Braeburn Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $109 |
| ABBVIE INC. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $18 |
Products named: SUBLOCADE, BRIXADI, ZEPBOUND, MAVYRET.
Industry payments across CA — which companies pay providers there.
